We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$381B
AUM Growth
+$27.2B
Cap. Flow
+$10.3B
Cap. Flow %
2.7%
Top 10 Hldgs %
19.31%
Holding
8,037
New
676
Increased
3,797
Reduced
2,511
Closed
409

Sector Composition

Rank Sector Weight
1 Financials 18.63%
2 Technology 14.62%
3 Industrials 7.94%
4 Healthcare 7.93%
5 Energy 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TECX
6776
Tectonic Therapeutic
TECX
$720M
$2K ﹤0.01%
194
+39
+25% +$441
QNTM
6777
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$20.8M
$2K ﹤0.01%
33
+5
+18% +$429
IVF
6778
INVO Fertility Inc
IVF
$1.73M
0
GRCE
6779
Grace Therapeutics
GRCE
$44.2M
$2K ﹤0.01%
585
ENZ
6780
DELISTED
Enzo Biochem, Inc.
ENZ
$2K ﹤0.01%
1,182
+182
+18% +$421
CRIT
6781
DELISTED
Optica Rare Earths & Critical Materials ETF
CRIT
$2K ﹤0.01%
+100
New +$1.95K
USAP
6782
DELISTED
Universal Stainless & Alloy
USAP
$2K ﹤0.01%
169
+158
+1,436% +$1.68K
SEEL
6783
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
HMNF
6784
DELISTED
HMN Financial Inc
HMNF
$2K ﹤0.01%
+133
New +$2.47K
GTHX
6785
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$2K ﹤0.01%
825
+149
+22% +$407
JEWL
6786
DELISTED
Adamas One Corp
JEWL
$2K ﹤0.01%
1,852
+352
+23% +$321
MMAT
6787
DELISTED
Meta Materials Inc. Common Stock
MMAT
$2K ﹤0.01%
93
-1
-1% -$24
OMIC
6788
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$2K ﹤0.01%
86
-88
-51% -$2.58K
ZFOX
6789
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
$2K ﹤0.01%
2,272
+387
+21% +$429
DCFC
6790
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
$2K ﹤0.01%
13
+11
+550% +$2.39K
KNTE
6791
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$2K ﹤0.01%
505
-1,634
-76% -$6.3K
CYT
6792
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$2K ﹤0.01%
888
+885
+29,500% +$1.85K
RAIN
6793
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$2K ﹤0.01%
1,593
+1,592
+159,200% +$7.96K
VAPO
6794
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$2K ﹤0.01%
+702
New +$3.22K
SCPL
6795
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$2K ﹤0.01%
100
FATH
6796
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$2K ﹤0.01%
204
+123
+152% +$1.12K
SUNL
6797
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
$2K ﹤0.01%
328
-39
-11% -$296
LTCHW
6798
DELISTED
Latch, Inc. Warrant expiring 6/4/2026
LTCHW
$2K ﹤0.01%
17,464
HGEN
6799
DELISTED
HUMANIGEN, INC.
HGEN
$2K ﹤0.01%
10,940
+4,065
+59% +$632
VECT
6800
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$2K ﹤0.01%
+135
New +$1.77K

Similar funds

Royal Bank of Canada's Q2 2023 Portfolio in Review

As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Royal Bank of Canada's Q2 2023 filing shows 676 new, 3,797 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.

  • Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
  • Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
  • Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
  • Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
  • Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
  • Royal Bank of Canada opened 676 new positions and closed 409 in Q2 2023.
  • Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.

Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.